Whitepaper

Emergence of Novel Immune - Mediated Therapies

Market Research

Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to grow due to the rise in the prevalence of diseases, the increase in the adoption of combination therapies, the surge in the funding for new therapies, and the approval of innovative therapies.  Numerous opportunities within the realm of immune therapies exist, considering the increasing prevalence of several diseases. Moreover, there is a notable upswing in funding for developing innovative therapies and a rising trend in novel immunotherapies approval.

Key Takeaways

  • Immune therapies offer a great source of hope for patients but are typically expensive, substantially contributing to the rising healthcare costs.
  • Upcoming immune therapies will be the majority for oncology indications, followed by infectious and autoimmune indications.
  • Multiple clinical trials are actively underway, examining the potential synergistic benefits of combining immunotherapy with other treatment modalities.

To know more...



Related Topics

ATxSG Broadcast Asia 2024

Whitepapers

ATxSG BroadcastAsia 2024: Key Trends

ATxSG is one of the leading technology conferences in Asia-Pacific with two primary focus avenues, i.e., BroadcastAsia and CommunicAsia, with close to...

NAB 2024 Key Trends

Whitepapers

NAB 2024 Key Trends

SG Analytics (SGA)’s media and broadcast research & consulting team surveyed 13 vendors attending the 2024 NAB Show in Las Vegas in April 2024....

Whitepaper - ESG-M&E - Sustainable Media

Whitepapers

A Shift toward Sustainable Media Consumption Imminent

Short description & Key Takeaways for the website: There are roughly 500+ OTT TV & video services globally with 6.3bn users worldwide generating...

We bring comprehensive data driven insights to everyone, everywhere